One of our goals in creating the inaugural Global Drug Policy Index (GDPI) was to encourage debate about how to best measure and compare states’ drug policies, and we therefore welcome well informed critical commentary. Although such commentary did feature in the World Report1 (for example, Harry Sumnall offered lucid and insightful criticism), we felt that this was not true across the piece.